Co-Diagnostics, Inc. (CODX) Total liabilities 2017–2025
Co-Diagnostics, Inc. (CODX) total liabilities at each fiscal year-end, per SEC filings.
$4.1MFY2025 · since FY2017: $811,802 → $4.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.1M | -57.5% |
| FY2024 | $9.7M | +4.1% |
| FY2023 | $9.3M | +8.6% |
| FY2022 | $8.6M | -66.5% |
| FY2021 | $25.6M | +462.9% |
| FY2020 | $4.5M | +849.8% |
| FY2019 | $478,070 | -81.7% |
| FY2018 | $2.6M | +221.8% |
| FY2017 | $811,802 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice